Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome
Background and Aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder. However, the underlying mechanism of IBS is not fully understood. The aim of this study was to investigate potential mechanism and novel biomarkers of IBS through evaluation of the metabolomic and m...
Main Authors: | Shengtao Zhu, Si Liu, Hengcun Li, Zheng Zhang, Qian Zhang, Lei Chen, Yu Zhao, Yang Chen, Junchao Gu, Li Min, Shutian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00346/full |
Similar Items
-
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
by: Maria Napolitano, et al.
Published: (2023-09-01) -
Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome
by: Si Liu, et al.
Published: (2019-05-01) -
Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Annamaria Altomare, et al.
Published: (2021-04-01) -
The efficacy of vitamin D supplementation for irritable bowel syndrome: narrow scope and GRADE miss-interpretation
by: Mohamed Abuelazm, et al.
Published: (2023-01-01) -
Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management
by: Herekar A, et al.
Published: (2023-06-01)